1. Home
  2. CABO vs REPL Comparison

CABO vs REPL Comparison

Compare CABO & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cable One Inc.

CABO

Cable One Inc.

HOLD

Current Price

$51.57

Market Cap

425.5M

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$8.82

Market Cap

407.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABO
REPL
Founded
1980
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
425.5M
407.1M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
CABO
REPL
Price
$51.57
$8.82
Analyst Decision
Hold
Hold
Analyst Count
4
9
Target Price
$125.67
$5.67
AVG Volume (30 Days)
197.4K
6.0M
Earning Date
04-30-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.25
EPS
6.12
N/A
Revenue
$1,501,423,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.83
N/A
P/E Ratio
$9.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.37
$1.50
52 Week High
$180.74
$13.24

Technical Indicators

Market Signals
Indicator
CABO
REPL
Relative Strength Index (RSI) 34.88 76.20
Support Level $45.37 $8.24
Resistance Level $117.15 $9.01
Average True Range (ATR) 4.67 0.65
MACD 1.66 0.34
Stochastic Oscillator 34.60 95.38

Price Performance

Historical Comparison
CABO
REPL

About CABO Cable One Inc.

Cable One Inc is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. The company derives majority of its revenue from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: